Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Seizure Prevention
Research conducted at Beaumount Hospital, Department of Neurology has provided new information about seizure prevention
June 26th, 2007
Fresh data on seizure are presented in the report "Outcome measurement after vagal nerve stimulation therapy: proposal of a new classification." According to a study from Dublin, Ireland, "Vagal nerve stimulation (VNS) is an adjunctive palliative therapy for refractory epilepsy. Effects of treatment are varied and some, such as the use of an external magnet for seizure termination, are unique to VNS." "No accepted standard exists for outcome measurement after VNS treatment. We present a novel classification for outcome, which includes assessment of both seizure frequency and severity in VNS-treated patients. We devised a classification system modeled on the Engel...
Source: Drug Law Weekly (2007-06-26)
|
